Cholesterol Drugs Extend Mesothelioma Survival in New Study
Cholesterol drugs called statins have been shown to improve survival among mesothelioma patients taking PD-1 inhibitors. The news comes from an international study from cancer researchers in Italy and the Netherlands. More than 250 patients with pleural mesothelioma or non-small cell lung cancer were evaluated for the study. Researchers found that those who took cholesterol drugs while also receiving PD-1 blockers like Keytruda lived longer and had slower disease progression. Mesothelioma Patients and Statins The body needs some cholesterol to build healthy cells. But many adults have too much cholesterol in their blood. This can lead to fatty deposits in the arteries that raise the risk for heart disease and stroke. Cholesterol drugs called statins are designed to bring cholesterol…